
The pharmaceutical industry seems besieged on all sides by declining R&D productivity, expiring patents and relentless downward pricing pressure. One effect of this onslaught has been an upsurge in the level of consolidation as industry players attempt to cut costs, expand research pipelines and lengthen geographic reach.
10-Jul-2008 - The splurge of acquisitions by Worldwide Clinical Trials (WCT) is continuing unabated with the company wrapping up the take over of MediQuest.
03-Jun-2008 - Kendle has announced the purchase of a privately owned early-phase contract research organisation (CRO) in Canada for an undisclosed sum.